New
Our First 2023 Newsletter is Now Available
In this newsletter, we discuss the latest research, current treatments, and potential developments in the field. Examine the correlations between the incidence of vitiligo and the chemical variables that influence the condition. Read the latest clinical trials news and get an in-depth look at the Vitiligo Drug Pipeline Analysis and Market Insights.
We hope that this will be a valuable resource for those affected by vitiligo and those looking to better understand the condition and its treatments.
If you missed it, you can read it here
FAQOther Questions
- What are the best predictors for therapy response in vitiligo?
A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...
- Is it Bitiligo? Vitaligo? Veteligo?
There are so many different ways that people try and spell or even pronounce Vitiligo. Here are some common mis-spellings: bitiligo, vitigo, vitaligo, vitilago, vitiglio, vitag...
- Does vitiligo increase the risk of skin cancer?
No, it does not. Despite common misconceptions, people with vitiligo are actually at a lower risk of developing skin cancer—including both nonmelanoma skin cancer (NMSC) and mal...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.